Premium Information is available for this item - Upgrade for $1 a day
5980-01-379-3157
Optoelectronic Display
5980013793157 013793157 779-3290-004
A component capable of displaying numeric, alphanumeric, symbolic, or graphic characters utilizing light emitting diode, plasma gas discharge, vacuum fluorescent, or liquid crystal display technology. For items designed to display information of a specific type, see INDICATOR, (as modified). View more Optoelectronic Display
January 2023
2
Marketplace 5980-01-379-3157
Request a Quotation from participating marketplace vendors
Related Documents 5980-01-379-3157 1+ Documents (More...)
5980-01-379-3157 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-59/fsc-5980/us 5980-01-379-3157
Optoelectronic Display 5980013793157 RQST NE Updated Every Day 5980-01-379-3157 RQST Updated Every Day
Restrictions 5980-01-379-3157
5980-01-379-3157 is a Optoelectronic Display that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item is a confirmed Commerce Control List Item (CCLI). This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 5980-01-379-3157
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 5980-01-379-3157
- United Kingdom (ZK01)
- Effective Date:
- 1 Aug 1993
Approved Sources 5980-01-379-3157
- Part Number
- Manufacturer
- Status
- 779-3290-004
- Manufacturer
- 13499 - Rockwell Collins, Inc. (Active)
- Primary Buy
- Primary Buy
Datasheet 5980-01-379-3157
- Characteristic
- Specifications
- FIIG
- Specifications
- A504Q0
- Special Features [FEAT]
- Runway Display; Cognizant Service - United Kingdom Royal Air Force
- End Item Identification [AGAV]
- Indicator Flight Director, Rockwell Intl Corp
Similar Supply Items to 5980-01-379-3157
Freight Information 5980-01-379-3157
5980-01-379-3157 has freight characteristics.. 5980-01-379-3157 has a variance between NMFC and UFC when transported by rail and the description should be consulted.